Nu Skin Enterprises, Inc. (NYSE:NUS) has earned a consensus recommendation of “Hold” from the eleven brokerages that are currently covering the firm, Marketbeat reports. Two research analysts have rated the stock with a sell recommendation, three have given a hold recommendation and five have given a buy recommendation to the company. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is $65.38.
Several research analysts have recently commented on the company. ValuEngine upgraded Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research report on Friday, February 2nd. Citigroup reiterated a “buy” rating and issued a $81.00 target price (up previously from $70.00) on shares of Nu Skin Enterprises in a research report on Tuesday, January 23rd. Finally, Zacks Investment Research upgraded Nu Skin Enterprises from a “sell” rating to a “hold” rating and set a $78.00 target price for the company in a research report on Saturday, December 30th.
In other news, Chairman Steven Lund sold 42,000 shares of Nu Skin Enterprises stock in a transaction that occurred on Wednesday, December 20th. The stock was sold at an average price of $68.11, for a total value of $2,860,620.00. Following the completion of the transaction, the chairman now owns 4,769 shares in the company, valued at approximately $324,816.59. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In the last quarter, insiders sold 195,978 shares of company stock valued at $13,512,733. Insiders own 5.20% of the company’s stock.
Shares of Nu Skin Enterprises (NYSE:NUS) traded up $0.94 on Friday, hitting $67.60. The stock had a trading volume of 444,686 shares, compared to its average volume of 326,632. The firm has a market cap of $3,509.65, a price-to-earnings ratio of 24.76, a price-to-earnings-growth ratio of 2.07 and a beta of 1.46. The company has a current ratio of 1.78, a quick ratio of 1.18 and a debt-to-equity ratio of 0.44. Nu Skin Enterprises has a one year low of $47.10 and a one year high of $74.45.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.